Work

Lenalidomide (Len) in Combination with Rituximab (R) Demonstrated Early Evidence of Efficacy in a Phase I/II Study in Relapsed/Refractory Mantle Cell Lymphoma (MCL).

Year: 2007

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v110.11.2562.2562

Authors: Michael Wang, Luis Fayad, Frederick Hagemeister, Sattva Neelapu, Barry Samuels, Felipe Samanigo, Barbara Pro, Qing Yi, Neda Bell, Catriona Byrne, Pam Weaver, Kim Hartig, Robert Knight, Jerry Zeldis, Larry Kwak, Jorge Romaguera

Institutions: The University of Texas MD Anderson Cancer Center, Celgene (United States)

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2559675858

FWCI: 0.414

Cites:

Cited by: 2

Related to: 10